Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 9/20 | 0.49 |
| ▸ | HTR2A | P28223 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | MGLL | Q99685 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.46 |
| ▸ | HTR7 | P34969 | 1/20 | 0.46 |
| ▸ | F10 | P00742 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9844499 | 0.93 | HTR2A (0.53) | GRM2HTR2AMEN1KMT2AKCNH2 | |
| SCHEMBL9844242 | 0.90 | HTR2A (0.52) | GRM2HTR2AHTR7 | |
| SCHEMBL9678985 | 0.90 | SIGMAR1 (0.52) | GRM2HTR2AMEN1KMT2AMGLL | |
| SCHEMBL9844329 | 0.87 | SIGMAR1 (0.54) | GRM2HTR2AMEN1KMT2AKCNH2 | |
| SCHEMBL9844308 | 0.83 | MAOA (0.56) | GRM2HTR2AMEN1KMT2AKCNH2 | |
| SCHEMBL9844433 | 0.83 | SIGMAR1 (0.45) | GRM2HTR2AKMT2AKCNH2 | |
| SCHEMBL9844336 | 0.82 | GRM2 (0.56) | GRM2HTR2AMGLLKCNH2HTR7 | |
| SCHEMBL9677080 | 0.82 | MEN1 (0.52) | GRM2HTR2AMEN1KMT2AKCNH2 | |
| SCHEMBL9844385 | 0.82 | SLC6A2 (0.58) | GRM2 | |
| SCHEMBL9844338 | 0.81 | GRM2 (0.51) | GRM2HTR2AMEN1KMT2AMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0443197-A2 | Oxazolidinones | MERCK PATENT GmbH (DE) | 1991-08-28 | — | — | EP | disclosed |